WallStreetZenWallStreetZen

NASDAQ: RNAC
Cartesian Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cartesian Therapeutics earnings were -$154.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest RNAC earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$39.2M, down 57.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RNAC reported annual earnings of -$130.3M, with 68.3% growth. The next RNAC earnings date is Aug 6, 2026.

RNAC earnings history

Current Revenue
$1.8M
Current Earnings
-$154.4M
Current Profit Margin
-8,698.7%

RNAC Return on Equity

Current Company
N/A
Current Industry
-142%
Current Market
13.5%

RNAC Return on Assets

Current Company
-45.9%
Current Industry
-13.7%
RNAC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RNAC announces earnings.

RNAC Return on Capital Employed

Current Company
-59.08%
Current Industry
-9.5%
RNAC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RNAC vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RNAC-$157.72M-$154.40MN/A-$5.90
IMRX-$53.74M-$54.44MN/A-$1.06
SRZN-$358.39M-$360.50MN/A-$41.34
AKBA$2.45M-$20.51MN/A-$0.08
ELDN-$79.14M-$79.50MN/A-$0.77
View Top Biotech Stocks

RNAC earnings dates

Next earnings date
Aug 6, 2026

Cartesian Therapeutics Earnings Reports & History FAQ

What were Cartesian Therapeutics's earnings last quarter?

Cartesian Therapeutics (NASDAQ: RNAC) reported Q1 2026 earnings per share (EPS) of -$1.46, up 114.71% year over year. Total RNAC earnings for the quarter were -$39.18 million. In the same quarter last year, Cartesian Therapeutics's earnings per share (EPS) was -$0.68.

If you're new to stock investing, here's how to buy Cartesian Therapeutics stock.

When does Cartesian Therapeutics report earnings?

The next RNAC earnings date is Invalid Date. Add RNAC to your watchlist to be reminded of Cartesian Therapeutics's next earnings date.

Is Cartesian Therapeutics profitable or losing money?

As of the last Cartesian Therapeutics earnings report, Cartesian Therapeutics is currently losing money. Cartesian Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$151.77 million, a 296.17% increase year over year.

What was RNAC's earnings growth in the past year?

As of Cartesian Therapeutics's earnings date in Q2 2026, Cartesian Therapeutics's earnings has grown year over year. RNAC earnings in the past year totalled -$154.40 million.

What are Cartesian Therapeutics's earnings expectations?

The current EPS estimate for Cartesian Therapeutics's earnings report in Invalid Date is -$0.77.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.